Beyond Glucose: Empagliflozin’s Impact on Fatty Liver in Patients with Type 2 Diabetes; A True Game Changer. Indus Journal of Bioscience Research, [S. l.], v. 3, n. 2, p. 193–198, 2025. DOI: 10.70749/ijbr.v3i2.663. Disponível em: https://www.ijbr.com.pk/IJBR/article/view/663. Acesso em: 18 aug. 2025.